|
|
||||||||
1 Department of Applied Biology, and
2
Insect Biomedical Research Center, and
3
Venture Laboratory, Kyoto Institute of Technology, Matsugasaki, Sakyo-ku, Kyoto 606-8585, Japan
4
Experimental Research Center for Infectious Diseases, Institute for Virus Research, Kyoto University, Sakyo-ku, Kyoto 606-8507, Japan
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
Here, we found an evolutionarily conserved region (amino acids 532–605) in the N-terminus of G9a, shared with GLP, and named it the G9a homology domain (GHD). In the present study, G9a-interacting proteins were screened by the yeast two-hybrid system using GHD of human G9a (hG9a) as the bait and the zinc finger protein 200 (ZNF200) was identified as an interactant. This protein was found to contain five C2H2-type zinc finger domains in tandem arrays, indicating that it is a member of Krüppel-type family (Bellefroid et al. 1991). The relevance of the observed interaction is supported by the observation that hG9a and ZNF200 at least partially co-localize, in the nucleoplasm. These results suggest that hG9a complexes may be recruited to specific chromosomal loci via interaction between GHD of hG9a and zinc finger domains of ZNF200.
| Results |
|---|
|
|
|---|
G9a is a lysine-preferring HMTase, first identified in mammals (Tachibana et al. 2001). Based on sequence information, the Drosophila homologue (Drosophila G9a; dG9a) of hG9a was identified. The Flybase gene code is CG2995 with the accession number of FBgn0040372. Sequence comparisons of the 1637 amino acids of dG9a and hG9a indicated overall identities of 28% (Fig. 1A). Human GLP (hGLP) is another H3-K9-specific HMTase (Ogawa et al. 2002). Sequence comparison of the 1267 amino acids of hGLP and hG9a indicate overall identities of 48% (Fig. 1A). Human G9a contains a SET domain flanked by two cysteine-rich regions in its C-terminal region known as pre-SET and post-SET (Fig. 1A). Recent studies suggest that the SET domain requires combination with these two adjacent cysteine-rich regions to exert HMTase activity (Rea et al. 2000). Drosophila G9a and hGLP are devoid of the post-SET domain, but characteristic cysteine residues are conserved.
|
Identification of ZNF200 as a protein interacting with hG9a
G9a belongs to the subfamily of HMTases with specificity for lysine 9 of histone H3 (Tachibana et al. 2001). H3-K9 methylation is associated with gene silencing and linked to the formation of heterochromatin (Bannister et al. 2001; Lachner et al. 2001). To generate further insight into the molecular mechanisms of the histone methylation-associated repression, we screened for hG9a-interacting proteins by yeast two-hybrid system using the N-terminal fragment of hG9a (amino acids 454–548, denoted hG9a454–548) contained in GHD as a bait (Fig. 1B). A plasmid library of fusions between the coding sequence for the GAL4 activation domain and cDNAs from human fetal brain cells was used as prey. Screening of 4.56 x 105 clones yielded a cDNA encoding a 238 amino acid protein.
A BLAST search revealed that the isolated cDNA corresponds to a part of human cDNA MGC: 45 293 (accession number BC032575). This cDNA encodes a ZNF200, whose function is yet unknown (Deng et al. 1998). As shown in Fig. 2, the ZNF200 protein contains five C2H2-type zinc finger domains in tandem arrays at its C-terminal region (Fig. 2B), indicating that the protein is a member of the Krüppel-type family (Schuh et al. 1986), which was originally identified with reference to the Xenopus laevis basal transcription factor TFIIIA and Drosophila melanogaster gap gene product Krüppel (Bellefroid et al. 1991). Usually located at the C-terminal region, the C2H2 motif contains two cysteines in an anti-parallel ß-sheet and two histidines in an
-helix. These four conserved amino acids tetrahedrally bind a zinc ion to form a globular domain (Pabo & Sauer 1992). The classical Krüppel-type C2H2 motif is 21 amino acids long and approximates the form CX2CX3FX8HX3H, where X represents any amino acid (Schuh et al. 1986). The portion of ZNF200 recovered in the yeast two-hybrid screen starts at amino acid residue 157 (pACT2-ZNF200157–395). Although ZNF200 was isolated by two-hybrid screen using GHD as a bait, its orthologues in other species such as mouse and Drosophila have not been identified on the genome database.
|
|
We have produced polyclonal anti-ZNF200 antibody and its specificity was evaluated by Western immunoblot analysis (Fig. 4A). With the anti-ZNF200 antibody, 50 kDa bands were detected on Western blots of extracts from HEK293 cells transfected with or without the EGFP-expression plasmids (Fig. 4A, lanes 1–3). Based on amino acid sequence, ZNF200 would be expected to migrate at 45 534 Da that is in the similar range of the observed 50 kDa immuno-reactive band. Both 73 and 50 kDa bands were detected in the extracts of HEK293 cells transfected with EGFP-ZNF200-expression plasmids (Fig. 4A, lane 3). The 73 kDa band also reacted with anti-GFP antibody, indicating that it represents exogenously expressed EGFP-ZNF200 (Fig. 4A, lane 6). The 27 kDa GFP protein was detected in extracts from cells transfected with the EGFP-expression plasmids on the same blot (Fig. 4A, lane 5). These results indicate that the anti-ZNF200 antibody can specifically detect the ZNF200 protein in the HEK293 cell extracts.
|
Association of ZNF200 with hG9a in vivo
To examine whether ZNF200 can associate with hG9a in vivo, HEK293 cells were transfected with expression plasmids for FLAGHA-tagged full-length hG9a (pFLAG-hG9a) and/or the full-length ZNF200 fused with EGFP (pEGFP-ZNF200). Whole-cell lysates were prepared and the immunoprecipitation was carried out with anti-FLAG antibodies, then the immunoprecipitates were analyzed for the presence of EGFP-ZNF200 fusion protein by immunoblot analysis with anti-GFP antibodies. Expectedly, FLAG-hG9a was detected with anti-FLAG antibodies in the immunoprecipitates from cells transfected with pFLAG-hG9a (Fig. 4C, lanes 6 and 8). EGFP-ZNF200 was detected with anti-GFP antibodies in the immunoprecipitates only when both FLAG-hG9a and EGFP-ZNF200 were co-expressed (Fig. 4C, lane 16). These results indicate that ZNF200 can associate with hG9a in human cells.
To further examine association of endogenous hG9a and ZNF200 proteins, cell extracts were immunoprecipitated with anti-ZNF200 antibody and then the immunoprecipitates were analyzed for the presence of hG9a by immunoblot analysis with anti-G9a antibody (Fig. 4D). The 180 kDa hG9a band in addition to the 50 kDa ZNF200 band was detected in the immunoprecipitate with the anti-ZNF200 antibody (Fig. 4D, lanes 3 and 5), but not with the control IgG (Fig. 4D, lanes 2 and 4). These results clearly indicate the association of ZNF200 with hG9a in vivo.
Subcellular localization
To further characterize the interaction between hG9a and ZNF200 in intact cells, we examined the subcellular localization of hG9a and ZNF200. Since anti-ZNF200 antibody cannot detect the endogenous ZNF200 in the immunostaining analysis of cells, we examined the subcellular localization of exogenously expressed hG9a and ZNF200 in human cells. Expression plasmids for FLAGHA-hG9a and EGFP-ZNF200 were co-introduced into HEK293 cells. In the interphase nuclei, both ZNF200 (green signals) and hG9a (red signals) was found to be localized in the nucleoplasm as discrete clear speckles (Fig. 5A,B). The subcellular localization of hG9a is consistent with a previous reports for EGFP-hG9a (Tachibana et al. 2001). When the two images were merged, overlapping foci appeared as yellow dots (Fig. 5D). These results suggest that ZNF200 and hG9a co-localize in most areas of nuclei.
|
At least two of the five zinc finger domains of ZNF200 are required for the interaction with hG9a
To map the region in ZNF200 responsible for binding to hG9a, we performed in vitro protein–protein interaction assays using GST fusion proteins. Five deletion derivatives of ZNF200 were produced and examined for their ability to interact with hG9a (Fig. 6A). HEK293 cells were transfected with pFLAG-hG9a DNA and cell extracts were prepared and subjected to GST pull-down assay using the GST-ZNF200 fusion protein or deletion derivatives. Deletion of the N-terminal region of ZNF200, generating ZNF157–395, exerted no effect on the interaction with hG9a (Fig. 6B, lane 9). Thus, the C-terminal region of ZNF200 that contains the five zinc fingers (ZF1–ZF5) is sufficient for effective interaction with hG9a. The C-terminal deletion derivative ZNF3–363, in which the C-terminal region corresponding to the ZF5 was deleted, effectively interacted with hG9a (Fig. 6B, lane 6), and another derivative ZNF3–335 carrying ZF1–ZF3 still retained the ability to interact with hG9a (Fig. 6B, lane 7). However, further deletion, generating ZNF3–279, in which ZF2–ZF5 were lacking, resulted in abrogation of the interaction with hG9a (Fig. 6B, lane 8). These results indicate that the C-terminal 60 amino acids of ZNF200, containing ZF4 and ZF5, are dispensable for the interaction with hG9a, with the minimal functional domain stretching from amino acids 157 to 335, a region containing ZF1–ZF3.
|
|
| Discussion |
|---|
|
|
|---|
In the present study, we found an evolutionarily conserved GHD domain in the N-terminal region of G9a and showed that amino acids 454–548 containing GHD interact with ZNF200 (amino acids157–395) in a two-hybrid assay (Fig. 3). Association between G9a and ZNF200 was further demonstrated by in vitro binding assays and immunoprecipitation experiments (Figs 4 and 5). Interestingly, the region within GHD of hG9a is also reported to be involved in the interaction with the other transcriptional repressor NRSF/REST (Roopra et al. 2004). Therefore, GHD is considered as a motif that serves to interact with other key regulatory proteins and G9a may be recruited to specific chromosomal loci via interaction between GHD and additional regulatory proteins.
The present study indicated that ZNF200 interacts with hG9a through a region stretching from amino acids 157 and 335, encompassing ZF1–ZF3 (Fig. 6). This region appears to be sufficient for the association with G9a. However, functions for the remaining two zinc fingers are yet to be clarified. Zinc finger domains, generally referred to as nucleic acid-binding or protein-interacting, are present in a large number of eukaryotic proteins, most of which are transcriptional regulators. If the remaining zinc fingers of ZNF200 have DNA-binding activity, ZNF200 may be a sequence-specific transcriptional factor that can recruit G9a to target genes in vivo.
The sub-cellular distribution of FLAGHA-hG9a indicates partial overlapping with EGFP-ZNF200 in the nucleus during interphase (Fig. 5D), ZNF200 being localized diffusely (Fig. 5A) while hG9a appeared in the nucleoplasm as rather discrete clear speckles, known to be regions outside of the heterochromatin domains around centromeric loci (Tachibana et al. 2001). Previous studies indicated that G9a could interact with other transcriptional repressors, such as NRSF/REST (Roopra et al. 2004), PRDI-BF1 (Gyory et al. 2004) and Cut (Nishio & Walsh 2004). Therefore, hG9a may form complexes with these factors in the nuclear region where no overlapping with ZNF200 signals is observed. Since green signals of ZNF200 are still observed when images are merged, it is also possible that ZNF200 plays roles other than recruiting G9a to the chromosome foci.
During metaphase, both FLAGHA-hG9a and EGFP-ZNF200 are dissociated from condensed mitotic chromosomes (Fig. 5). On the other hand, a previous report described endogenous SUV39H1 to specifically accumulate at centromeric positions of human metaphase chromosomes (Aagaard et al. 1999), indicating a contribution to their structural organization. In the present study, FLAGHA-hG9a exhibited a quite different localization pattern in metaphase cells, presumably reflecting differences between G9a and SUV39H1 functions. Since ZNF200 is also dissociated from mitotic chromosomes, it may not be a component of the scaffold. Although the hypothesis needs to be tested with specific antibodies against endogenous molecules, the present findings suggest a possibility that G9a and ZNF200 may not be involved in the organization of higher order chromatin structures during metaphase, but rather contribute to regulation of chromatin structure during interphase. Since co-expression of G9a with GAL4-DBD-ZNF200 fusion protein exerted no effect on transcription of the transfected reporter gene carrying GAL4-binding sites, interaction between G9a and ZNF200 may require chromatin structure. In addition, since both G9a and ZNF200 are highly expressed in testis (Deng et al. 1998; Tachibana et al. 2001), they may contribute to regulation of the testis-specific chromatin structure.
| Experimental procedures |
|---|
|
|
|---|
All constructs refer to the amino acid sequence as reported in NP_003 445 (National Center for Biotechnology Information). Full-length ZNF200 cDNA was obtained by site-directed mutagenesis of an EST clone (Clone ID: 5 260 695, Open Biosystems) which carries a single nucleotide deletion at the position 271 A. To insert the nucleotide, polymerase chain reactions (PCR) were performed using the EST clone as a template with two synthetic oligonucleotide primers (5'-GTGCATCCTCGTCCCTTGGTGAAGCTTCTGCCCAAAGGAGTCC and 5'-GGACTCCTTTGGGCAGAAGCTTCACCAAGGGACGAGGATGCAC) containing the nucleotide insertions shown in bold letters. Site-directed mutagenesis was performed with a QuickChange Site-Directed Mutagenesis Kit (Stratagene).
For the expression of Aequorea victoria green fluorescent protein (EGFP) fused to full-length ZNF200, ZNF200 cDNA was obtained by PCR amplification using two synthetic oligonucleotide primers (5'-AAGAGATCTTGGCTTCAAAAGTGGTTCCTATG-3' and 5'-TTCGTCGACTTACTTCTGCTTTCGGGTCTTACAG-3'), and inserted between the BglII and SalI sites in pEGFP-C2 (Clontech) to create pEGFP-ZNF200.
For the preparation of glutathione S-transferase (GST) fusion recombinant proteins, cDNA fragments corresponding to ZNF2003–395, ZNF2003–363, ZNF2003–335 and ZNF2003–279 were produced by PCR amplification using appropriate primers (5'-AAGGTCGACTGGCTGCAAAAGTGGTTCC-3' and each primer; 5'-GGTGCGGCCGCTTACTTCTGCTTTCGGGTC-3', 5'-CACATTTTGCGGCCGCTTATGGTCTCTCAGCC-3', 5'-CACATTCTGCGGCCGCTTATATCTTCTCCCTTATATG-3' or 5'-CACAGTGAGCGGCCGCTTAGGGTTTTTCTCC-3', respectively), and cloned into the SalI and NotI sites in pGEX4T-1 (GE Healthcare). pGST-ZNF200157–395 was created by subcloning the BamHI/XhoI insert from pACT2-ZNF200157–395 into pGEX-5X-1 (GE Healthcare).
Full-length hG9a1–1210 tagged with the FLAG and HA epitope sequences (pIRESneo-FLAGHA-hG9a) was described earlier (Tachibana et al. 2005). For protein expression in yeast cells, the DNA fragment corresponding to hG9a454–584 and GLP522–612 were obtained by PCR amplification using synthetic oligonucleotide primers (5'-AGTCGAATTCGAAAAGCTGTCAGGCTGCAAT-3' and 5'-AGTCGGATCCTTAGATGGTCACCTCTTGAGCTTGAGA-3') or (5'-CGAGAATTCCGGTGCACAAACAGCGTGG-3' and 5'-GCCGGATCCTTAAGCTATCGTCACCTCTTTGG-3') and inserted between EcoRI and BamHI sites in pGBKT7 (Clontech) to create pGBKT7-hG9a454–548 and pGBKT7-hGLP522–612, respectively.
Both nucleotide sequencing and restriction enzyme digestion verified the identities of all constructs.
Yeast two-hybrid screen
The yeast two hybrid screen was performed using the pre-transformed MATCHMAKER library system (Clontech). Cells of yeast strain AH109 (MATa, trip1-901, leu2-3, 112, ura3-52, his3-200, gal4
, gal80
, LYS2::GAL1UAS-GAL1TATA-HIS3, GAL2UAS-GAL2TATA-ADE2 URA3::MEL1UAS-MEL1TATA-LacZ MEL1) transformed with pGBKT7-hG9a454–548 were mated with Y187 cells (MAT
, ura3-52, his3-200, ade2-101, trp1-901, leu2-3, 112, gal4
, gal80
, met–, URA3::GAL1UAS-GAL1TATA-lacZ, MEL1) pre-transformed with human fetal brain cDNA/pACT2. Diploid his +, ade +, trp +, leu + transformants were selected on minimal medium lacking histidine, adenine, tryptophan and leucine, and supplemented with 2% glucose and 2.5 mM 3-amino-1,2,4-triazole. They were further confirmed to express ß-galactosidase with 5-bromo-4-chloro-3-indoryl-ß-D-galactopyranoside (X-Gal) as a substrate. Plasmid DNAs, isolated from yeast candidate clones, were transfected to transform E. coli KC8 carrying hisB, leuB and trpC mutations. KC8 cells transformed with the pACT2 plasmid were grown on M9 minimal medium supplemented with essential amino acids and thiamine but lacking leucine.
In the yeast two-hybrid assay, bait (empty pGBKT7, pGBKT7-hG9a454–548 or pGBKT7-hGLP522–612) and target (empty pACT2 or pACT2-ZNF157–395) plasmids were co-transformed into AH109 S. cerevisiae. Colonies were isolated and their ability to grow in the absence or presence of histidine and adenine was assessed.
Cell culture, transfections and luciferase assays
HEK293 cell lines were cultured in DMEM (Invitrogen) supplemented with 10% fetal bovine serum, 100 units/mL of penicillin and 100 µg/mL of streptomycin at 37 °C in a 5% CO2 atmosphere and transfected with plasmid DNAs using FuGene 6 reagent (Roche) according to the manufacturer's instructions.
HeLa cells were seeded into 24-well dishes (1.5 x 104 cells/well) and cultured for 20 h before transfection with 47 ng of pGL3-G5polß (Sekimata et al. 2001), 3 ng of SV40-RL (Promega) and indicated amounts of the expression plasmids. After incubation for 48 h, cell lysates were prepared and assayed for luciferase activity using a luciferase assay kit (Promega). For expression of a GAL4-DBD fused to ZNF200, ZNF200
Zn, ZNF200-Zn, pM-ZNF200, pM-ZNF200
Zn and pM-ZNF200-Zn were generated by subcloning a SalI-SpeI fragment of ZNF200 encoding amino acids (aa) 3–395, EcoRI-XhoI fragment of ZNF200 encoding aa3–251, BamHI-XbaI fragment of ZNF200 encoding aa252–395 into the plasmid pM (Clonthech). For expression of a HA-tagged ZNF200, the fragment digested with BglII/SalI of pEGFP-C2-ZNF200 was cloned into BamHI/XhoI of the plasmid pcDNA3 (Invitrogen) to create the plasmid pcDNA3-HA-ZNF200.
Antibodies
GST-ZNF2003–393 fusion protein was expressed in E. coli BL21 (DE3). Lysates of cells were prepared by sonication in PBS containing 0.1% Triton X-100 and a mixture of protease inhibitors (Roche). The lysates were applied to GSTrap HP to purify the GST-ZNF2003–393 fusion protein according to the manufacturer's instructions (GE Healthcare). Anti-ZNF200 antibody was produced in rabbits by injection of the purified GST-ZNF2003–393 fusion protein. Rabbit serum was applied to MabTrap Protein G HP using MabTrap kit (GE Healthcare) to purify total rabbit IgG.
Immunoprecipitation
HEK293 cells were lysed with lysis buffer (20 mM Tris [pH8.0], 0.4 M KCl, 1 mM EDTA, 10% glycerol, 5 mM MgCl2, 0.1% Tween 20) containing a mixture of protease inhibitors (Nacalai tesque). The cell extracts equivalent to 1.5 mg protein was then added to Protein A Sepharose beads (GE Healthcare) cross-linked with anti-ZNF200 antibody. Normal rabbit IgG (Sigma) was used to immunoprecipitation the same amount of cell extract as a negative control. Samples were rotated 16 h at 4 °C. Sepharose beads were washed 3 times with wash buffer (10 mM Tris [pH7.5], 150 mM NaCl, 0.1% Nonidet P-40). The protein complex was eluted in PBS containing 2% SDS and analyzed by Western blot using anti-ZNF200 antibody (1 : 250 dilution) and anti-mouse G9a antibody (MBL, 1 : 10 dilution). Visualization was carried out using Super Signal West femto Maximum Sensitivity Substrate (Pierce).
HEK293 cells were plated in 6 cm diameter dishes (5 x 105/dish), cultured for 20 h, and co-transfected with pEGFP-ZNF200 and pIRESneo-FLAGHA-hG9a. The total amount of expression plasmids transfected was adjusted to 4 µg. After 48 h incubation, cells were harvested and suspended in lysis buffer (20 mM Hepes, 0.42 M NaCl, 1.5 mM MgCl2, 0.1% NP40, 20% glycerol, 0.5 mM PMSF, 0.5 mM DTT, and a mixture of protease inhibitors containing 4-(2-aminoethyl) benzenesulfonyl fluoride, aprotinin, E-64, leupeptin, pepstain, pepstatin A). After centrifugation for 30 min at 15 000g, supernatants were incubated with agarose conjugated with anti-FLAG IgG1 (ANTI-FLAG M2 affinity gel, Sigma). After incubation for 16 h at 4 °C, the beads were washed 3 times with the same buffer, and the immune complexes were collected and subjected to Western blot analysis. Bound FLAG tagged hG9a and EGFP tagged ZNF200 were detected with anti-FLAG monoclonal antibodies (ANTI-FLAG M5, Sigma), anti-GFP monoclonal antibodies (Clontech) and an ECL detection kit (GE Healthcare).
GST pull-down assay
HEK293 cells were transfected with pIRESneo-FLAGHA-hG9a, then cells were harvested and subjected to GST pull-down assays. The amounts of proteins were determined by BCA Protein Assay Reagent Kit (Pierce). GST or GST-ZNF200 fusion proteins were produced in E. coli BL21 (DE3) and purified with glutathione-Sepharose beads equilibrated with PBS. The amounts of each GST fusion protein were estimated by SDS-PAGE. Beads loaded with 10 µg of GST fusion proteins were rocked at 4 °C with 400 µg of HEK293 whole-cell extracts. After incubation for 16 h at 4 °C, the beads were washed 3 times with the wash buffer (10 mM Tris–HCl, pH 7.4, 150 mM NaCl, 1 mM Na3VO4, 0.1% NP40) and bound proteins were subjected to Western blot analysis. Bound hG9a was detected by immunoblotting with anti-FLAG monoclonal antibodies (ANTI-FLAG M5, Sigma) and an ECL detection kit.
Fluorescent microscope analysis
HEK293 cells grown on glass coverslips were co-tranfected with pIRESneo-FLAGHA-hG9a and pEGFP-ZNF200 by the method described above, fixed with 4% paraformaldehyde in PBS for 30 min, and permeabilized with 0.2% Triton X-100 in PBS for 5 min. After washing with PBS, samples were blocked with 1% skim milk in PBS for 10 min. After washing with PBS, the samples were then incubated for 1 h with anti-HA Rat monoclonal antibody (clone 3F10, 1 : 150 dilution, Roche), washed further 3 times with 0.1% NP40 in PBS, and blocked again with 1% skim milk in PBS for 10 min. The samples were then incubated for 30 min with Alexa Fluor 594-conjugated secondary antibody (Molecular Probes, 1 : 400 dilution). After washing 3 times with 0.1% NP40 in PBS, the samples were stained with 4', 6-diamino-2-phenylindole (DAPI) for 5 min and examined under a confocal laser scanning microscope (LSM510, Carl Zeis).
| Acknowledgements |
|---|
| Footnotes |
|---|
aPresent address: Developmental Biology, Stanford School of Medicine, 279 Campus Dr. B371, Stanford, CA 94305, USA.
| References |
|---|
|
|
|---|
Aggarwal, B.D. & Calvi, B.R. (2004) Chromatin regulates origin activity in Drosophila follicle cells. Nature 430, 372–376.[CrossRef][Medline]
Bannister, A.J., Zegerman, P., Partridge, J.F., Miska, E.A., Thomas, J.O., Allshire, R.C. & Kouzarides, T. (2001) Selective recognition of methylated lysine 9 on hisotne H3 by the HP1 chromo domain. Nature 410, 120–124.[CrossRef][Medline]
Bellefroid, E.J., Poncelet, D.A., Lecocq, P.J., Revelant, O. & Martial, J.A. (1991) The evolutionarily conserved Krüppel-associated box domain defines a subfamily of eukaryotic multifingered proteins. Proc. Natl. Acad. Sci. USA 88, 377–387.
Chen, D., Ma, H., Hong, H., Koh, S.S., Huang, S.M., Schurter, B.T., Aswad, D.W. & Stallcup, M.R. (1999) Regulation of transcription by a protein methyltransferase. Science 284, 2174–2177.
Deng, Z., Centola, M., Chen, X., Sood, R., Vedula, A., Fischel-Ghodsian, N. & Kastner, D.L. (1998) Identification of two Krüppel-related zinc finger genes (ZNF200 and ZNF210) from human chromosome 16p13.3. Genomics 53, 97–103.[CrossRef][Medline]
Freemont, P.S., Hanson, I.M. & Trousdale, J. (1991) A novel cysteine-rich sequence element. Cell 64, 483–484.[CrossRef][Medline]
Grunstein, M. (1997) Histone acetylation in chromatin structure and transcriptional. Nature 389, 349–352.[CrossRef][Medline]
Gyory, I., Wu, J., Fejer, G., Seto, E. & Wright, K.L. (2004) PRDI-BF1 recruits the histone H3 methyltransferase G9a in transcriptional silencing. Nat. Immunol. 5, 299–308.[CrossRef][Medline]
Jenuwein, T., Laible, G., Dorn, R. & Reuter, G. (1998) SET-domain proteins modulate chromatin domains in eu-and heterochromatin. Cell. Mol. Life Sci. 54, 80–93.[CrossRef][Medline]
Lachner, M., OCarroll, D., Rea, S., Mechtler, K. & Jenuwein, T. (2001) Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature 410, 116–120.[CrossRef][Medline]
Melcher, M., Schmid, M., Aagaard, L., Selenko, P., Laible, G. & Jenuwein, T. (2000) Structure–function analysis of SUV39H1 reveals a dominant role in heterochromatin organization, chromosome segregation, and mitotic progression. Mol. Cell. Biol. 20, 3728–3741.
Nishio, H. & Walsh, M.J. (2004) CCAAT displacement protein/cut homolog recruits G9a histone lysine methyltransferase to repress transcription. Proc. Natl. Acad. Sci. USA 101, 11257–11262.
Nishioka, K., Chuikov, S., Sarma, K., Erdjument-Bromage, H., Allis, C.D., Tempst, P. & Reinberg, D. (2002) Set9, a novel histone H3 methyltransferase that facilitates transcription by precluding histone tail modifications required for heterochromatin formation. Genes Dev. 16, 479–489.
Ogawa, H., Ishiguro, K., Gaubatz, S., Livingston, D.M. & Nakatani, Y. (2002) A complex with chromatin modifiers that occupies E2F- and Myc-responsive genes in G0 cells. Science 296, 1132–1136.
Pabo, C.D. & Sauer, R.T. (1992) Transcriptional factors: structural families and principles of DNA recognition. Annu. Rev. Biochem. 61, 1053–1096.[CrossRef][Medline]
Peters, A.H., Kubicek, S., Mechtler, K., O'Sullivan, R.J., Derijck, A.A.H.A., Perez-Burgos, L., Kohimaier, A., Opravil, S., Tachibana, M., Shinkai, Y., Martens, J.H.A. & Jenuwein, T. (2003) Partitioning and plasticity of repressive histone methylation states in mammalian chromatin. Mol. Cell 12, 1577–1589.[CrossRef][Medline]
Peters, A.H.F.M., OCarroll, D., Scerthan, H., Mechtler, K., Sauer, S., Schofer, C., Weipoltshammer, K., Pagani, M., Lachner, M., Kohlmaier, A., Opravil, S., Doyle, M., Sibilia, M. & Jenuwein, T. (2001) Loss of the Suv39 h Histone methyltansferases impairs mammalian heterochromatin and genome stability. Cell 107, 323–337.[CrossRef][Medline]
Rea, S., Eisenfaber, F., OCarroll, D., Strahl, B.D., Sun, Z.W., Schmid, M., Opravil, S., Mechtler, K., Ponting, C.P., Allis, C.D. & Jenuwein, T. (2000) Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature 406, 593–599.[CrossRef][Medline]
Rice, J.C., Briggs, S.D., Ueberheide, B., Barber, C.M., Shabanowitz, J., Hunt, D.F., Shinkai, Y. & Allis, C.D. (2003) Histone methyltransferases direct different degrees of methylation to define distinct chromatin domains. Mol. Cell 12, 1591–1598.[CrossRef][Medline]
Roopra, A., Qazi, R., Schoenike, B., Daley, T.J. & Morrison, J.F. (2004) Localized domains of G9a-mediated histone methylation are required for silencing of neuronal genes. Mol. Cell 14, 727–738.[CrossRef][Medline]
Schuh, R., Aicher, W., Gaul, U., Cote, S., Preiss, A., Maier, D., Seifert, E., Nauber, U., Schroder, C., Kemler, R. & Jackle, H. (1986) A conserved family of nuclear proteins containing structural elements of the finger protein encoded by Krüppel, a Drosophila segmentation gene. Cell 47, 1025–1032.[CrossRef][Medline]
Sekimata, M., Takahashi, A., Murakami-Sekimata, A. & Homma, Y. (2001) Involvement of a novel zinc finger protein, MIZF, in transcriptional repression by interacting with a methyl-CpG-binding protein, MBD2. J. Biol. Chem. 276, 42632–42638.
Tachibana, M., Sugimoto, K., Hukushima, T. & Shinkai, Y. (2001) SET domain-containing protein, G9a, is a novel lysine-preferring mammalian histone methyltransferase with hyperactivity and specific selectively to lysines 9 and 27 of histone H3. J. Biol. Chem. 276, 25309–25317.
Tachibana, M., Sugimoto, K., Nozaki, M., Ueda, J., Ohta, T., Ohki, M., Fukuda, M., Takeda, N., Niida, H., Kato, H. & Shinkai, Y. (2002) G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis. Genes Dev. 16, 1779–1791.
Tachibana, M., Ueda, J., Fukuda, M., Takeda, N., Ohta, T., Iwanari, H., Sakihama, T., Kodama, T., Hamakubo, T. & Shinkai, Y. (2005) Histone methyltransferase G9a and GLP form heteromeric complexes and are both crucial for methylation of euchromatin at H3-K9. Genes Dev. 19, 815–826.
Wang, H., Cao, R., Xia, L., Erdjument-Bromage, H., Borchers, C., Tempst, P. & Zhang, Y. (2001) Purification and functional characterization of histone H3-lysine 4-specific methyltransferase. Mol. Cell 8, 1207–1217.[CrossRef][Medline]
Wei, Y., Yu, L., Bowen, J., Gorovsky, M.A. & Allis, C.D. (1999) Phosphorylation of histone H3 is required for proper chromosome condensation and segregation. Cell 97, 99–109.[CrossRef][Medline]
Zhang, Y. & Reinberg, D. (2001) Transcription regulation by histone methylation: interplay between different covalent modifications of the core histone tails. Genes Dev. 15, 2343–2360.
Accepted: 16 April 2007
This article has been cited by other articles:
![]() |
Y. Kato, M. Kato, M. Tachibana, Y. Shinkai, and M. Yamaguchi Characterization of Drosophila G9a in vivo and identification of genetic interactants. Genes Cells, July 1, 2008; 13(7): 703 - 722. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | ADVANCED SEARCH | TABLE OF CONTENTS |